Ignite Creation Date:
2024-05-06 @ 7:15 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05946421
Status:
RECRUITING
Last Update Posted:
2023-07-14
First Post:
2023-07-07
Brief Title:
The BASA Study Breath Analysis for Severe Asthma Patients
Sponsor:
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Organization:
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Study Overview
Official Title:
The BASA Study Breath Analysis for Severe Asthma Patients A New Non-invasive Approach for the Monitoring of Inflammation in Severe Asthma Patients on Biologics
Status:
RECRUITING
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the fluctuations of exhaled breath markers in patients with severe asthma on biologics In the study severe asthma patients will be followed up to 16 weeks monitoring lung function and inflammation through non-invasive technologies such as exhaled breath analysis FeNO GC-MS and EBC A control group will be followed up to two weeks with the overall objective to indentify and evaluate the modifcations of markers of inflammation in patient under biologic treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None